Constraint Induced Movement Therapy for Walking in Individuals Post Stroke
Sponsored by Shirley Ryan AbilityLab
About this study
To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.
To determine the effect of constraint induced movement therapy (CIMT) on locomotor function in individuals post stroke. In order to compare the effect of CIMT vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be blocked by gait speed into slow (\< 0.4 m/s) or fast (≥ 0.4 m/s) subgroups and randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated, excluding set up time. D…
Where this study is enrolling
- I'm interested
Abilitylab
Chicago, Illinois
Who can participate
Inclusion criteria
- ✓1. age between 21 and 75 years;
- ✓2. history of unilateral, supratentorial, ischemic or hemorrhagic stroke;
- ✓3. no prior stroke;
- ✓4. demonstration of impaired walking function (self-selected walking speed ≤ 0.80 m/s);
- ✓5. able to stand and walk (\>10 meters) without physical assistance.
Exclusion criteria
- ✕1. significant cardiorespiratory/metabolic disease;
- ✕2. other neurological or orthopedic injury that impairs locomotion;
- ✕3. scores on the Mini Mental Status examination \< 24;
- ✕4. stroke of the brainstem or cerebellar lesions;
- ✕5. uncontrolled hypertension (systolic \> 200 mm Hg, diastolic \> 110 mm Hg);
- ✕6. botox injection within 6 months of starting the study.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.